Digest Network Come funziona
Network
/
Società
Qu
Non verificato

Quince Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

34 comunicati stampa

Guarda tutti i comunicati
10/12/2025
Industria
Biotecnologia
HIV, AIDS e malattie autoimmuni
Salute
Farmaceutica
Medicina - Varie
Quince Therapeutics Announces Publication of Use of eDSP in Early-Stage Clinical Studies in Pulmonary and Inflammatory Bowel Disorders
Fonte
Quince Therapeutics, Inc.
Emittente
Business Wire
1.00
0
24/11/2025
Eventi
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Quince Therapeutics to Participate at Investor Events in December 2025
Fonte
Quince Therapeutics, Inc.
Emittente
Business Wire
1.00
0
12/11/2025
Mercato azionario
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Quince Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
Fonte
Quince Therapeutics, Inc.
Emittente
Business Wire
1.00
0
10/11/2025
Industria
Scienza
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Sanità
Quince Therapeutics Announces Positive iDSMB Review for eDSP in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia
Fonte
Quince Therapeutics, Inc.
Emittente
Business Wire
1.00
0
09/10/2025
Oncologia
Salute
Scienza
Farmaceutica
Biotecnologia
Industria
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting
Fonte
Quince Therapeutics, Inc.
Emittente
Business Wire
1.00
0
25/09/2025
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study
Fonte
Quince Therapeutics, Inc.
Emittente
Business Wire
1.00
0
11/09/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Web e Social Network
Eventi
Quince Therapeutics to Host Virtual Investor Day on October 2, 2025
Fonte
Quince Therapeutics, Inc.
Emittente
Business Wire
1.00
0
02/09/2025
Biotecnologia
Salute
Scienza
Farmaceutica
Eventi
Web e Social Network
Quince Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
Fonte
Quince Therapeutics, Inc.
Emittente
Business Wire
1.00
0
11/08/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Mercato azionario
Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
Fonte
Quince Therapeutics, Inc.
Emittente
Business Wire
1.00
0
07/08/2025
Biotecnologia
Farmaceutica
Salute
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP
Fonte
Quince Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0